1.498
Pliant Therapeutics Inc Borsa (PLRX) Ultime notizie
Can Pliant Therapeutics Inc. stock maintain operating marginsJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
Pliant Therapeutics Inc. stock trend forecast2025 Investor Takeaways & Capital Efficiency Focused Strategies - newser.com
Has Pliant Therapeutics Inc. found a price floorJuly 2025 Analyst Calls & Low Risk Investment Opportunities - newser.com
What to expect from Pliant Therapeutics Inc. in the next 30 daysJuly 2025 Decliners & Consistent Growth Equity Picks - newser.com
Will Pliant Therapeutics Inc. bounce back from current supportJuly 2025 PostEarnings & Community Consensus Trade Alerts - newser.com
Price momentum metrics for Pliant Therapeutics Inc. explainedJuly 2025 Breakouts & Free Community Consensus Stock Picks - newser.com
Can you recover from losses in Pliant Therapeutics Inc.Volume Spike & Weekly Watchlist of Top Performers - newser.com
What analysts say about Pliant Therapeutics Inc stockDividend Cut Warnings & Low Risk Investment Plans - earlytimes.in
Pliant Therapeutics' (PLRX) Underweight Rating Reiterated at JPMorgan Chase & Co. - MarketBeat
JPMorgan downgrades Pliant Therapeutics stock rating to Underweight from Neutral - Investing.com Canada
Pliant Therapeutics Shares Fall After JPMorgan Downgrade - MarketScreener
Pliant Therapeutics Inc. stock outlook for YEARMarket Growth Review & Capital Protection Trade Alerts - newser.com
Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook - Seeking Alpha
JPMorgan Downgrades Pliant Therapeutics to Underweight From Neutral - MarketScreener
PLRX Downgraded by JP Morgan: Today's Key Analyst Rating Update - GuruFocus
Order flow analysis tools used on Pliant Therapeutics Inc.July 2025 Intraday Action & Community Consensus Stock Picks - newser.com
Pliant Therapeutics (NASDAQ:PLRX) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Does Pliant Therapeutics Inc. stock trade at a discount to peersTrade Risk Assessment & Long-Term Safe Return Strategies - newser.com
Is Pliant Therapeutics Inc. (9PT) stock testing key supportPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
Is Pliant Therapeutics Inc. (9PT) stock a top pick for value investorsGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Detecting price anomalies in Pliant Therapeutics Inc. with AIJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
Evaluating Pliant Therapeutics Inc. with trendline analysis2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Why Pliant Therapeutics Inc. (9PT) stock attracts wealthy investorsJuly 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com
How sustainable is Pliant Therapeutics Inc. stock dividend payoutJobs Report & Free Technical Pattern Based Buy Signals - newser.com
Published on: 2025-10-03 01:17:50 - newser.com
How Pliant Therapeutics Inc. (9PT) stock reacts to new regulationsEarnings Recap Report & Consistent Return Strategy Ideas - newser.com
Applying big data sentiment scoring on Pliant Therapeutics Inc.Gold Moves & Low Risk High Reward Trade Ideas - newser.com
Technical analysis overview for Pliant Therapeutics Inc. stockQuarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Will Pliant Therapeutics Inc. (9PT) stock keep raising dividendsQuarterly Portfolio Report & Trade Opportunity Analysis - newser.com
Visualizing Pliant Therapeutics Inc. stock with heatmaps2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):